Healthy Participants

Healthy/Normal·MeSH: Renal Insufficiency, Chronic
125 drugs in development·30 companies·89 clinical trials

Drug Pipeline by Phase

Phase 3(33)
Phase 1(66)
DrugCompany
[13C2,15N3]-tebapivatAGIOS PHARMACEUTICALS, INC. (AGIO)
[14C]-tebapivatAGIOS PHARMACEUTICALS, INC. (AGIO)
[14c]azd5004ASTRAZENECA PLC (AZN)
[14c]azd5004 solution for infusionASTRAZENECA PLC (AZN)
100 µci [14c] hmpl-306HUTCHMED (China) Limited (HCM)
aci-19764 at dose a1AC Immune SA (ACIU)
aci-19764 at dose a2AC Immune SA (ACIU)
aci-19764 at dose a3AC Immune SA (ACIU)
aci-19764 at dose a4AC Immune SA (ACIU)
aci-19764 at dose a5AC Immune SA (ACIU)
aci-19764 at dose a6AC Immune SA (ACIU)
aci-19764 at dose b1AC Immune SA (ACIU)
aci-19764 at dose b2AC Immune SA (ACIU)
aci-19764 at dose b3AC Immune SA (ACIU)
AG-236AGIOS PHARMACEUTICALS, INC. (AGIO)
Andexanet alfaASTRAZENECA PLC (AZN)
ApixabanASTRAZENECA PLC (AZN)
azd5004 film-coatedASTRAZENECA PLC (AZN)
blu-808Blueprint Medicines Corp (BPMC)
BW-50218 InjectionCidara Therapeutics, Inc. (CDTX)
CasdatifanArcus Biosciences, Inc. (RCUS)
CDX-622Celldex Therapeutics, Inc. (CLDX)
combined oral contraceptiveDeciphera Pharmaceuticals, Inc. (DCPH)
CRB-913Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CRB-913Crinetics Pharmaceuticals, Inc. (CRNX)
dextromethorphanASTRAZENECA PLC (AZN)
elecoglipronASTRAZENECA PLC (AZN)
elenestinibBlueprint Medicines Corp (BPMC)
esomeprazoleIncyte Corp. (INCY)
ethinyl estradiol/levonorgestrelASTRAZENECA PLC (AZN)
evolocumab drug substance aAMGEN INC (AMGN)
evolocumab drug substance bAMGEN INC (AMGN)
ezetimibe stpASTRAZENECA PLC (AZN)
famotidineIncyte Corp. (INCY)
Fluzone HD influenza vaccineCidara Therapeutics, Inc. (CDTX)
itraconazoleIncyte Corp. (INCY)
ItraconazoleArcus Biosciences, Inc. (RCUS)
KT-579Kymera Therapeutics, Inc. (KYMR)
levonorgestrel/ethinyl estradiolBlueprint Medicines Corp (BPMC)
ly3009104ELI LILLY & Co (LLY)
LY4060874ELI LILLY & Co (LLY)
ly4100511ELI LILLY & Co (LLY)
midazolamBlueprint Medicines Corp (BPMC)
MitiglinideASTRAZENECA PLC (AZN)
moxifloxacinELI LILLY & Co (LLY)
nal erTrevi Therapeutics, Inc. (TRVI)
nintedanibTrevi Therapeutics, Inc. (TRVI)
nnc0113-6856Novo Nordisk A/S (NVO)
nnc0650-0013 aNovo Nordisk A/S (NVO)
PhenytoinArcus Biosciences, Inc. (RCUS)
PioglitazoneASTRAZENECA PLC (AZN)
pmn310ProMIS Neurosciences Inc. (PMN)
QuemliclustatArcus Biosciences, Inc. (RCUS)
rabeprazoleELI LILLY & Co (LLY)
rabeprazoleHUTCHMED (China) Limited (HCM)
rabeprazoleHUTCHMED (China) Ltd (HMDCF)
rifampinIncyte Corp. (INCY)
RivaroxabanASTRAZENECA PLC (AZN)
rosuvastatinDeciphera Pharmaceuticals, Inc. (DCPH)
semaglutide cNovo Nordisk A/S (NVO)
STAR-0310Astria Therapeutics, Inc. (ATXS)
syh2085NYMOX PHARMACEUTICAL CORP (NYMXF)
tbp-pi-hbrSpero Therapeutics, Inc. (SPRO)
ziltivekimab bNovo Nordisk A/S (NVO)
ziltivekimab cNovo Nordisk A/S (NVO)
ziltivekimab dNovo Nordisk A/S (NVO)
Phase 1/Phase 2(1)
Phase 2/Phase 3(1)

Compare drugs

Frequently asked questions

How many drugs are in development for Healthy Participants?

BioSniper tracks 125 drugs in development for Healthy Participants across 30 companies.

How many clinical trials target Healthy Participants?

There are 89 clinical trials targeting Healthy Participants tracked by BioSniper.

Deep-dive into Healthy Participants

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis